We are live on
!
Find out more
FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-0.26%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$98.7M
AUM Growth
-$18.3M
(-16%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-12.37%
Top 10 Holdings %
Top 10 Hldgs %
32.82%
Holding
132
New
6
Increased
20
Reduced
59
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$1.57M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$354K |
| 3 |
Abbott
ABT
|
+$250K |
| 4 |
Invesco Senior Loan ETF
BKLN
|
+$221K |
| 5 |
Public Service Enterprise Group
PEG
|
+$196K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$1.79M |
| 2 |
Gilead Sciences
GILD
|
+$951K |
| 3 |
Maximus
MMS
|
+$772K |
| 4 |
CVS Health
CVS
|
+$758K |
| 5 |
Align Technology
ALGN
|
+$557K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.95% |
| 2 | Energy | 10.59% |
| 3 | Consumer Staples | 8.55% |
| 4 | Real Estate | 7% |
| 5 | Technology | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CVS Health
CVS
$133B
| $4.92M | 4.99% |
47,460
-7,800
| -14% | -$758K |
|
|
2
Gilead Sciences
GILD
$162B
| $4.43M | 4.49% |
48,281
-10,550
| -18% | -$951K |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.98M | 4.03% |
194,852
-11,159
| -5% | -$354K |
|
4
Altria Group
MO
$114B
| $3.89M | 3.95% |
62,138
-7,375
| -11% | -$446K |
|
5
iShares US Consumer Staples ETF
IYK
$1.4B
| $3.34M | 3.39% |
89,106
-10,800
| -11% | -$384K |
|
6
Biogen
BIIB
$30B
| $2.62M | 2.65% |
10,055
-1,750
| -15% | -$462K |
|
|
STON
7
DELISTED
StoneMor Inc.
STON
| $2.58M | 2.62% |
105,845
+1,800
| +2% | +$47.5K |
|
8
Iron Mountain
IRM
$36.4B
| $2.27M | 2.3% |
66,891
-85
| -0.1% | -$2.44K |
|
9
Philip Morris
PM
$297B
| $2.18M | 2.21% |
22,238
-3,350
| -13% | -$307K |
|
|
10
Align Technology
ALGN
$12.1B
| $2.16M | 2.19% |
29,750
-8,500
| -22% | -$557K |
|
11
Synaptics
SYNA
$4.19B
| $2.16M | 2.19% |
27,090
| – | – |
|
12
Johnson & Johnson
JNJ
$618B
| $2.1M | 2.13% |
19,407
-3,280
| -14% | -$340K |
|
13
ExxonMobil
XOM
$644B
| $1.91M | 1.93% |
22,806
-3,000
| -12% | -$240K |
|
14
Visa
V
$684B
| $1.85M | 1.87% |
24,140
-4,325
| -15% | -$314K |
|
|
15
Weyerhaeuser
WY
$18B
| $1.82M | 1.84% |
+58,632
| New | +$1.57M |
|
16
Ares Capital
ARCC
$13.5B
| $1.65M | 1.67% |
110,827
+1,500
| +1% | +$20.7K |
|
17
iShares MSCI Canada ETF
EWC
$6.13B
| $1.58M | 1.6% |
66,683
-2,300
| -3% | -$49.3K |
|
18
iShares US Utilities ETF
IDU
$1.35B
| $1.57M | 1.59% |
25,380
-3,000
| -11% | -$173K |
|
19
VanEck Agribusiness ETF
MOO
$972M
| $1.56M | 1.58% |
33,475
-300
| -0.9% | -$13.4K |
|
20
Union Pacific
UNP
$174B
| $1.54M | 1.57% |
19,420
-3,750
| -16% | -$290K |
|
21
Phillips 66
PSX
$84.9B
| $1.52M | 1.55% |
17,608
-4,300
| -20% | -$349K |
|
22
Yum! Brands
YUM
$41.8B
| $1.34M | 1.35% |
22,707
-278
| -1% | -$14.6K |
|
23
SBA Communications
SBAC
$19.2B
| $1.32M | 1.34% |
13,200
-1,500
| -10% | -$143K |
|
24
Medtronic
MDT
$109B
| $1.18M | 1.19% |
15,677
| – | – |
|
25
Cencora
COR
$60.6B
| $1.12M | 1.14% |
12,950
-5,100
| -28% | -$454K |
|
Similar funds
CIM
CSWM
WWP
GWM
FWM
MWS
AP
AA
Fernwood Investment Management's Q1 2016 Portfolio in Review
As of Q1 2016, Fernwood Investment Management held 132 positions worth $98.7M, down 16% from $117M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Fernwood Investment Management withdrew a net $12.2M in Q1 2016, closing 11 positions and reducing 59 holdings. Its most notable exit was PLUM CREEK TIMBER CO (REIT), an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Energy and Consumer Staples.
Against the trend, Fernwood Investment Management opened a new position in Weyerhaeuser worth $1.82M.
- Fernwood Investment Management's largest Q1 2016 buy was Weyerhaeuser: 58,632 shares worth $1.82M.
- Fernwood Investment Management added most to AbbVie in Q1 2016, an estimated $134K increase.
- Fernwood Investment Management's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $951K.
- Fernwood Investment Management fully exited PLUM CREEK TIMBER CO (REIT) in Q1 2016, selling an estimated $1.79M.
- Fernwood Investment Management's ten largest holdings make up 33% of its $98.7M portfolio in Q1 2016.
- Fernwood Investment Management opened 6 new positions and closed 11 in Q1 2016.
- Fernwood Investment Management's portfolio value fell 16% quarter-over-quarter to $98.7M.
Based on Fernwood Investment Management's 13F filing for Q1 2016, filed 10 May 2016.